Wird geladen...

Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137 Expressing Regulatory T Cells

Adoptive immunotherapy with anti-tumor T cells is a promising novel approach to the treatment of cancer. However, T cell therapy may be limited by the co-transfer of regulatory T cells (Tregs). Here we explored this hypothesis by using two cell surface markers, CD44 and CD137, to isolate anti-tumor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Goldstein, Matthew J, Kohrt, Holbrook E, Houot, Roch, Varghese, Bindu, Lin, Jack T, Swanson, Erica, Levy, Ronald
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294169/
https://ncbi.nlm.nih.gov/pubmed/22232735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-3375
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!